Al-Razi Medical Co. (9572) is listed on Nomu of the Saudi Exchange (Tadawul) under sector Health Care Equipment & Svc. Financial data sourced from CMA-mandated XBRL filings via Sahm Screener (sahmscreener.com).

For fiscal year 2024, Al-Razi Medical Co. reported revenue of SAR 61M, net profit of SAR 176K, and earnings per share of SAR 0.12. Total assets stood at SAR 41M with total equity of SAR 23M and total liabilities of SAR 18M.

Operating cash flow for 2024 was SAR 5M, representing a cash conversion ratio of 28.19 relative to net profit. Free cash flow was SAR 1M.

Earnings quality analysis by Sahm Screener: Of every SAR 1.00 in reported net profit for 2024, SAR 28.19 arrived as operating cash. This indicates Exceptional quality earnings based on the cash conversion ratio of 28.19.

Revenue growth from 2023 to 2024: +0.0%. Net profit growth over the same period: -74.4%.

Key financial ratios for 2024: Return on Equity 0.8%, Return on Assets 0.4%, Net Margin 0.3%, Debt to Equity 0.81.

In 2023, Al-Razi Medical Co. reported revenue of SAR 61M and net profit of SAR 686K, compared to SAR 61M and SAR 176K respectively in 2024.